The Role of PBR/TSPO in Steroid Biosynthesis Challenged
Overview
Authors
Affiliations
Translocator protein 18 kDa: a potential therapeutic biomarker for post traumatic stress disorder.
Qiu Z, Liu X, Chen Y, Wu R, Guan S, Pan Y Metab Brain Dis. 2020; 35(5):695-707.
PMID: 32172519 DOI: 10.1007/s11011-020-00548-9.
Effects of genetic variants in the TSPO gene on protein structure and stability.
Milenkovic V, Bader S, Sudria-Lopez D, Siebert R, Brandl C, Nothdurfter C PLoS One. 2018; 13(4):e0195627.
PMID: 29641545 PMC: 5895031. DOI: 10.1371/journal.pone.0195627.
Global Deletion of TSPO Does Not Affect the Viability and Gene Expression Profile.
Wang H, Zhai K, Xue Y, Yang J, Yang Q, Fu Y PLoS One. 2016; 11(12):e0167307.
PMID: 27907096 PMC: 5131929. DOI: 10.1371/journal.pone.0167307.
Cerebrovascular and microglial states are not altered by functional neuroinflammatory gene variant.
Felsky D, De Jager P, Schneider J, Arfanakis K, Fleischman D, Arvanitakis Z J Cereb Blood Flow Metab. 2016; 36(4):819-30.
PMID: 26762507 PMC: 4821029. DOI: 10.1177/0271678X15626719.
Evolving understanding of translocator protein 18 kDa (TSPO).
Li F, Liu J, Garavito R, Ferguson-Miller S Pharmacol Res. 2015; 99:404-9.
PMID: 25882248 PMC: 4567528. DOI: 10.1016/j.phrs.2015.03.022.